Home FDA labels 22952813-7ab3-47ca-95c1-8c90d5416635 FDA label 22952813-7ab3-47ca-95c1-8c90d5416635 openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
SPL set ID aeb31b41-4304-427d-a78c-10f7d2e98316
SPL ID 22952813-7ab3-47ca-95c1-8c90d5416635
Version 2
Effective date 2019-09-30
Source export date 2026-11-06
Source partition 3
Source file https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-11-06/97001096994db9ca8cee114e6c3bb5298d3c573158ffc1ab8692d82e76a3eb40/drug-label-0003-of-0014.json.zip
Source manifest SHA-256 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run 20261108T063105Z
Imported at 2026-11-08 06:53:53 Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 2 matching rows.
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 2 matching rows.
adverse reactions ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Perioral dermatitis Itching Allergic contact dermatitis Irritation Maceration of the skin Dryness Secondary infection Folliculitis Skin atrophy Hypertrichosis Striae Acneiform eruptions Miliaria Hypopigmentation
adverse reactions table <table> <col width="21%"/> <col width="27%"/> <tbody> <tr> <td styleCode=" Botrule Toprule Lrule " valign="top"> <paragraph>Burning</paragraph> </td> <td styleCode=" Botrule Toprule Lrule " valign="top"> <paragraph>Perioral dermatitis</paragraph> </td> </tr> <tr> <td styleCode=" Botrule Lrule " valign="top"> <paragraph>Itching</paragraph> </td> <td styleCode=" Botrule Lrule " valign="top"> <paragraph>Allergic contact dermatitis</paragraph> </td> </tr> <tr> <td styleCode=" Botrule Lrule " valign="top"> <paragraph>Irritation</paragraph> </td> <td styleCode=" Botrule Lrule " valign="top"> <paragraph>Maceration of the skin</paragraph> </td> </tr> <tr> <td styleCode=" Botrule Lrule " valign="top"> <paragraph>Dryness</paragraph> </td> <td styleCode=" Botrule Lrule " valign="top"> <paragraph>Secondary infection</paragraph> </td> </tr> <tr> <td styleCode=" Botrule Lrule " valign="top"> <paragraph>Folliculitis</paragraph> </td> <td styleCode=" Botrule Lrule " valign="top"> <paragraph>Skin atrophy</paragraph> </td> </tr> <tr> <td styleCode=" Botrule Lrule " valign="top"> <paragraph>Hypertrichosis</paragraph> </td> <td styleCode=" Botrule Lrule " valign="top"> <paragraph>Striae</paragraph> </td> </tr> <tr> <td styleCode=" Botrule Lrule " valign="top"> <paragraph>Acneiform eruptions</paragraph> </td> <td styleCode=" Botrule Lrule " valign="top"> <paragraph>Miliaria</paragraph> </td> </tr> <tr> <td styleCode=" Botrule Lrule " valign="top"> <paragraph>Hypopigmentation</paragraph> </td> <td styleCode=" Botrule Lrule " valign="top"/> </tr> </tbody> </table>
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.